Study: Injectable Drugs Cut Risk of Blindness-Related Nursing Home Admission

Researchers have found that injectable drugs introduced in the last decade have decreased the risk of blindness-related nursing home admission by close to 20 percent among people with wet macular degeneration.

The drugs, Lucentis and Avastin, inhibit vascular endothelial growth factors (they're commonly referred to as anti-VEGF mediations). The researchers found that within two years of receiving anti-VEGF injections, recipients were 19 percent less likely to be admitted to a long-term care facility.

Compared to earlier treatments, anti-VGEFs reduce vision loss by more than 40 percent and slow the onset of severe vision loss and blindness by more than 45 percent.

To learn more, click here.